RLAY Q1 2021 Earnings — Relay Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

RLAYRelay Therapeutics, Inc.

$2B

Q1 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$952,000

Gross Profit

-$30M-3116.6% margin

Operating Income

-$42M-4454.3% margin

Net Income

-$42M-4431.1% margin

EPS (Diluted)

$-0.47

QoQ Revenue Growth

-98.8%

Cash Flow

Operating Cash Flow

$47M

Free Cash Flow

$46M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$771M

Total Liabilities

$39M

Stockholders' Equity

$733M

Cash & Equivalents

$263M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$952,000	$0	—
Gross Profit	-$30M	$0	—
Operating Income	-$42M	-$26M	-60.3%
Net Income	-$42M	-$25M	-69.5%